Newswire

Newswire

Brii Bio Presents Positive Phase 3 Data on BRII-196/BRII-198, the Company’s SARS-CoV-2 Monoclonal Neutralizing Antibody Combination Therapy, in an Oral Late-Breaker Presentation at IDWeek 2023

DURHAM, N.C.and BEIJING, Oct. 3, 2023 /PRNewswire/ — Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, presented at IDWeek 2023 interim results…

Global Metal Finishing Procurement – Sourcing and Intelligence Report Predicts This Market to Surpass USD 3 Billion, Rising at 5.39% CAGR from 2020 to 2024 – Exclusive Report by SpendEdge

Key Points Covered in the Metal Finishing Market Report: Am I engaging with the right suppliers? Which KPIs should I use to evaluate my incumbent suppliers? Which supplier selection criteria are relevant for ERP Software? What are the ERP Software category essentials…